Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment

EA Gormley, DJ Lightner, M Faraday… - The Journal of …, 2015 - auajournals.org
Purpose: The purpose of this guideline amendment, herein referred to as the amendment, is
to incorporate relevant newly published literature to better provide a clinical framework for …

Urinary incontinence in women

LN Wood, JT Anger - Bmj, 2014 - bmj.com
Urinary incontinence affects women of all ages. History, physical examination, and certain
tests can guide specialists in diagnosing stress urinary incontinence, urgency urinary …

[HTML][HTML] Efficacy and safety of mirabegron add-on therapy to solifenacin in incontinent overactive bladder patients with an inadequate response to initial 4-week …

MJ Drake, C Chapple, AA Esen, S Athanasiou… - European urology, 2016 - Elsevier
Background Incontinence has a greater detrimental effect on quality of life than other
symptoms of overactive bladder (OAB) and is often difficult to treat with antimuscarinic …

Overactive bladder syndrome: evaluation and management

E Leron, AY Weintraub, SA Mastrolia, P Schwarzman - Current urology, 2018 - karger.com
Overactive bladder (OAB) syndrome is a chronic medical condition which has a major
influence on the quality of life in a significant amount of the population. OAB affects …

Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: randomized …

I Ramírez‐García, L Blanco‐Ratto… - Neurourology and …, 2019 - Wiley Online Library
Aim To evaluate the non‐inferiority of the transcutaneous electrical stimulation technique, as
compared with the percutaneous therapy (PTNS), regarding the efficacy in symptoms and …

An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract …

A Mangera, A Apostolidis, KE Andersson, P Dasgupta… - European urology, 2014 - Elsevier
Abstract Context Botulinum toxin A (BoNTA) has received regulatory approval for use in
neurogenic detrusor overactivity (NDO) and overactive bladder (OAB), but it remains …

[HTML][HTML] CUA guideline on adult overactive bladder

J Corcos, M Przydacz, L Campeau… - Canadian Urological …, 2017 - ncbi.nlm.nih.gov
The. overactive. bladder.(OAB). picture. has. dramatically. changed. in. the. last. 20. years..
A. quarter. century. ago,. this. symptom. complex. did. not. even. exist.. Bladder. hyperactivity …

Evaluation and treatment of overactive bladder in women

R Raju, BJ Linder - Mayo Clinic Proceedings, 2020 - Elsevier
Overactive bladder (OAB) is a symptom complex that includes urinary urgency, frequency,
urgency incontinence, and nocturia. It is highly prevalent, affecting up to 12% of the adult …

A practical approach to the management of nocturia

M Oelke, S De Wachter, MJ Drake… - … journal of clinical …, 2017 - Wiley Online Library
Aim To raise awareness on nocturia disease burden and to provide simplified aetiologic
evaluation and related treatment pathways. Methods A multidisciplinary group of nocturia …

The role of obesity on urinary incontinence and anal incontinence in women: a review

SK Doumouchtsis, J Loganathan… - BJOG: An International …, 2022 - Wiley Online Library
Obesity prevalence is increasing worldwide, with significant healthcare implications. We
searched PubMed/MEDLINE, Embase and the Cochrane Library for articles registered until …